Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul 14;54(13):4619-26.
doi: 10.1021/jm200310q. Epub 2011 Jun 9.

Structure-based design of novel boronic acid-based inhibitors of autotaxin

Affiliations
Free PMC article

Structure-based design of novel boronic acid-based inhibitors of autotaxin

Harald M H G Albers et al. J Med Chem. .
Free PMC article

Abstract

Autotaxin (ATX) is a secreted phosphodiesterase that hydrolyzes the abundant phospholipid lysophosphatidylcholine (LPC) to produce lysophosphatidic acid (LPA). The ATX-LPA signaling axis has been implicated in inflammation, fibrosis, and tumor progression, rendering ATX an attractive drug target. We recently described a boronic acid-based inhibitor of ATX, named HA155 (1). Here, we report the design of new inhibitors based on the crystal structure of ATX in complex with inhibitor 1. Furthermore, we describe the syntheses and activities of these new inhibitors, whose potencies can be explained by structural data. To understand the difference in activity between two different isomers with nanomolar potencies, we performed molecular docking experiments. Intriguingly, molecular docking suggested a remarkable binding pose for one of the isomers, which differs from the original binding pose of inhibitor 1 for ATX, opening further options for inhibitor design.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1. Autotaxin (ATX) is Responsible for Hydrolyzing the Lipid Lysophosphatidylcholine (LPC) into Lysophosphatidic Acid (LPA) and Choline
Figure 1
Figure 1
ATX structure liganded with inhibitor 1 (PDB ID 2XRG). (A) Surface representation of ATX with inhibitor 1 (magenta). (B) Binding of inhibitor 1 to the threonine oxygen nucleophile and two zinc ions. (C) Visualizing the ether linker of inhibitor 1 bound to ATX. (D) Visualizing the degree of freedom for the thiazolidine-2,4-dione core of inhibitor 1 in the ATX binding site.
Scheme 2
Scheme 2. Synthetic Route Towards Linker Modified Inhibitors
Scheme 3
Scheme 3. Synthetic Routes Towards Core Modified Inhibitors
Figure 2
Figure 2
(A) Focus from inside the protein on the thiazolidine-2,4-dione core of inhibitor 1 bound to ATX. (B) Inhibitor 1 docked into the active site of ATX to validate our docking approach. (C) The three best docking poses for the Z-isomer of 28. (D) The three best docking poses for the E-isomer of 28. Docking poses were generated using the docking program Glide.

References

    1. Tokumura A.; Majima E.; Kariya Y.; Tominaga K.; Kogure K.; Yasuda K.; Fukuzawa K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 2002, 277, 39436–39442. - PubMed
    1. Umezu-Goto M.; Kishi Y.; Taira A.; Hama K.; Dohmae N.; Takio K.; Yamori T.; Mills G. B.; Inoue K.; Aoki J.; Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 2002, 158, 227–233. - PMC - PubMed
    1. Moolenaar W. H.; van Meeteren L. A.; Giepmans B. N. The ins and outs of lysophosphatidic acid signaling. Bioessays 2004, 26, 870–881. - PubMed
    1. Kanda H.; Newton R.; Klein R.; Morita Y.; Gunn M.; Rosen S. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat. Immunol. 2008, 9, 415–423. - PMC - PubMed
    1. van Meeteren L.; Moolenaar W. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 2007, 46, 145–160. - PubMed

Publication types

Substances

LinkOut - more resources